The FDA has approved the first generic versions of Lilly’s Zyprexa (olanzapine tablets) and Zyprexa Zydis (olanzapine orally disintegrating tablets) to treat schizophrenia and bipolar disorder. Generic olanzapine tablets will be manufactured by Dr. Reddy’s Laboratories. and Teva Pharmaceuticals USA. Generic olanzapine orally disintegrating tablets will be manufactured by Apotex, Dr. Reddy’s Laboratories, and Par Pharmaceuticals.
For more information visit www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm277022.htm.